These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 140047)

  • 21. Fructose 2,6-bisphosphate and glucose 1,6-bisphosphate levels in erythrocytes with high and low 2,3-bisphosphoglycerate content during postnatal development.
    Gallego C; Carreras J
    FEBS Lett; 1989 Jul; 251(1-2):74-8. PubMed ID: 2753166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activation by AMP and cyclic-AMP of rat erythrocyte and reticulocyte glycolysis.
    Luque J; Roncalés P; Tejero C; Pinilla M
    Acta Biol Med Ger; 1977; 36(5-6):631-8. PubMed ID: 203150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of the hexokinase-phosphofructokinase system on the basis of an extended PFK-model.
    Otto M; Jacobasch G; Svetina S
    Acta Biol Med Ger; 1977; 36(3-4):581-5. PubMed ID: 145776
    [No Abstract]   [Full Text] [Related]  

  • 24. Red cell phosphofructokinase and pyruvate kinase activities correlate with genetic variation of 2, 3-bisphosphoglycerate in rats.
    Gilman JG
    Biochem Biophys Res Commun; 1981 Sep; 102(2):766-74. PubMed ID: 6458301
    [No Abstract]   [Full Text] [Related]  

  • 25. Inorganic phosphate amplifies the effects of AMP and fructose-2,6-bisphosphate on yeast phosphofructokinase.
    Przybylski F; Nissler K; Schellenberger W; Hofmann E
    Biomed Biochim Acta; 1985; 44(11-12):1559-65. PubMed ID: 2936338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Description of the kinetics of the two substrate reactions S1+S2 goes to and comes from S3+S4 by a generalized Monod, Wyman, Changeux model].
    Popova SV; Sel'kov EE
    Mol Biol (Mosk); 1979; 13(1):129-39. PubMed ID: 156878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-association of human erythrocyte phosphofructokinase. Kinetic behaviour in dependence on enzyme concentration and mode of association.
    Wenzel KW; Kurganov BI; Zimmermann G; Yakovlev VA; Schellenberger W; Hofmann E
    Eur J Biochem; 1976 Jan; 61(1):181-90. PubMed ID: 128461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of ADP and fructose-2,6-bisphosphate with phosphofructokinase-1 from yeast.
    Nissler K; Schellenberger W; Otto A; Hofmann E
    Biomed Biochim Acta; 1985; 44(7-8):1065-70. PubMed ID: 2935144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic criterion of the feasibility of the Monod-Wyman-Changeux model.
    Kurganov BI; Yakovlev VA
    Mol Biol; 1972; 6(1):91-5. PubMed ID: 4263936
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of 2,3-DPG on red cell phosphofructokinase.
    Beutler E; Guinto E
    FEBS Lett; 1973 Nov; 37(1):21-2. PubMed ID: 4270992
    [No Abstract]   [Full Text] [Related]  

  • 31. Mathematical analysis of multienzyme systems. I. Modelling of the glycolysis of human erythrocytes.
    Rapoport TA; Heinrich R
    Biosystems; 1975 Jul; 7(1):120-9. PubMed ID: 168932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of phosphoglucomutase by fructose 2,6-bisphosphate.
    Bartrons R; Carreras M; Climent F; Carreras J
    Biochim Biophys Acta; 1985 Sep; 842(1):52-5. PubMed ID: 2931119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementarity in the regulation of phosphoglucomutase, phosphofructokinase and hexokinase; the role of glucose 1,6-bisphosphate.
    Beitner R; Haberman S; Livni L
    Biochim Biophys Acta; 1975 Aug; 397(2):355-69. PubMed ID: 125609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identity of sulfate and phosphate activation of the phosphofructokinase from erythrocytes.
    Kühn B; Jacobasch G; Rapoport SM
    FEBS Lett; 1974 Jan; 38(3):354-6. PubMed ID: 4277519
    [No Abstract]   [Full Text] [Related]  

  • 35. Kinetics of 6-phosphofructo-1-kinase from a yeast mutant.
    Bigl M; Eschrich K; Hofmann E
    Biomed Biochim Acta; 1991; 50(3):239-50. PubMed ID: 1835381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cortisol on erythrocyte and reticulocyte enzymes: modulation of phosphofructokinase properties.
    Kwiatkowska D; Szajerka G; Kwiatkowska J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):381-7. PubMed ID: 6228205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fructose 2,6-bisphosphate in rat erythrocytes. Inhibition of fructose 2,6-bisphosphate synthesis and measurement by glycerate 2,3-bisphosphate.
    Sobrino F; Rider MH; Gualberto A; Hue L
    Biochem J; 1987 May; 244(1):235-8. PubMed ID: 2822000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic effects of fructose-1,6-bisphosphate on yeast phosphofructokinase.
    Otto A; Przybylski F; Nissler K; Schellenberger W; Hofmann E
    Biomed Biochim Acta; 1986; 45(7):865-75. PubMed ID: 2947575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fructose-2,6-bisphosphate increases the binding affinity of yeast phosphofructokinase to AMP.
    Kessler R; Nissler K; Schellenberger W; Hofmann E
    Biochem Biophys Res Commun; 1982 Jul; 107(2):506-10. PubMed ID: 6215040
    [No Abstract]   [Full Text] [Related]  

  • 40. Thermal inactivation differences of phosphofructokinase in erythrocytes from genetically selected high and low DPG rat strains.
    Chassin SL; Kruckeberg WC; Brewer GJ
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1306-11. PubMed ID: 151544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.